BASF Venture Capital invests in Allylix

Published: 12-Mar-2012

Deal will enable BASF to broaden its use of renewable substances


BASF Venture Capital has invested $13.5m in US based renewable speciality chemicals company Allylix Inc. The BASF subsidiary led a $18.2m financing round joined by existing investors Tate & Lyle Ventures, Avrio Ventures and Cultivian Ventures.

Allylix has a proprietary technology platform to produce a variety of renewable speciality chemicals, including terpenes and their derivatives. The fermentation based technology allows for the creation of pure, renewable compounds, previously only available from natural sources and in limited quantities.

“Our investment in Allylix could allow us to broaden our use of renewable raw materials for sustainable chemical solutions in the future and leverage our competency in aroma chemicals, nutrition and cosmetic chemicals,” said Dr Daniela Proske, principal at BASF Venture Capital America.

Carolyn Fritz, president and ceo of Allylix added: “Our biotechnological and cost competitive manufacturing process for speciality chemicals, such as aroma chemicals, will address the consumer preference for affordable and naturally derived products. This round of funding will support the development and delivery of new compounds in Allylix’s pipeline and will allow us to expand the market for our existing products.”

You may also like